Ocumension Therapeutics
Status: Publicly traded
Direct answer
Ocumension Therapeutics is publicly traded on HKSE under the ticker 1477.HK.
Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic...
Can you invest in Ocumension Therapeutics?
Yes. Ocumension Therapeutics trades publicly on HKSE as 1477.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ocumension Therapeutics
Detailed equity research is provided by MarketSnap.